{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:45:22Z","timestamp":1790383522315,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ancard.2017.10.012","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T02:19:40Z","timestamp":1509502780000},"page":"373-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thrombose coronaire\u00a0: physiopathologie et traitement \u00e0 l\u2019\u00e8re de la m\u00e9decine personnalis\u00e9e"],"prefix":"10.1016","volume":"66","author":[{"given":"M.","family":"Zeitouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Silvain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kerneis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Guedeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Overtchouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Barthelemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hauguel-Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ancard.2017.10.012_bib0225","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/heartjnl-2012-301700","article-title":"French registry on acute ST-elevation and non ST-elevation myocardial infarction 2010. FAST-MI 2010","volume":"98","author":"Hanssen","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ancard.2017.10.012_bib0230","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.1912.04270120001001","article-title":"Clinical features of sudden obstruction of the coronary arteries","volume":"59","author":"Herrick","year":"1912","journal-title":"JAMA"},{"key":"10.1016\/j.ancard.2017.10.012_bib0235","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM198010163031601","article-title":"Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction","volume":"303","author":"De Wood","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.012_bib0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM199201303260502","article-title":"Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes","volume":"326","author":"Mizuno","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.012_bib0245","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.012_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9149(95)80017-M","article-title":"Systemic nature of endothelial dysfunction in atherosclerosis","volume":"75","author":"Anderson","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ancard.2017.10.012_bib0255","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.CIR.90.2.988","article-title":"Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis","volume":"90","author":"Mailhac","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2017.10.012_bib0260","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1074\/jbc.272.13.8137","article-title":"Agonist-activated \u03b1v\u03b23\u00a0on platelets and lymphocytes binds to the matrix protein osteopontin","volume":"272","author":"Bennett","year":"1997","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.ancard.2017.10.012_bib0265","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI117501","article-title":"Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis","volume":"94","author":"Fitzpatrick","year":"1994","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.ancard.2017.10.012_bib0270","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jacc.2010.09.077","article-title":"Composition of coronary thrombus in acute myocardial infarction","volume":"57","author":"Silvain","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ancard.2017.10.012_bib0275","first-page":"53","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"299","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ancard.2017.10.012_bib0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197807132990201","article-title":"A Randomized trial of aspirin and sulfinpyrazone in threatened stroke","volume":"299","author":"The Canadian Cooperative Study Group","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.012_bib0285","first-page":"231","article-title":"Aspirin and cancer risk: a summary review to 2007. Recent results","volume":"181","author":"Bosetti","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ancard.2017.10.012_bib0290","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Aspirin trial and the UK-TIA aspirin trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ancard.2017.10.012_bib0295","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1161\/CIRCULATIONAHA.113.002236","article-title":"Long-term effects of secondary prevention on cognitive function in stroke patients","volume":"128","author":"Douiri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ancard.2017.10.012_bib0300","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.012_bib0305","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.012_bib0310","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jacc.2010.07.012","article-title":"New P2Y12\u00a0inhibitors versus clopidogrel in percu-taneous coronary intervention: a meta-analysis","volume":"56","author":"Bellemain-Appaix","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.ancard.2017.10.012_bib0315","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ancard.2017.10.012_bib0320","author":"Ibanez","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2017.10.012_bib0325","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehp118","article-title":"Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials","volume":"30","author":"De Luca","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ancard.2017.10.012_bib0330","author":"Valgimigli","year":"2017","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.ancard.2017.10.012_bib0335","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.98.20.2126","article-title":"Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)","volume":"98","author":"Urban","year":"1998","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ancard.2017.10.012_bib0340","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.98.16.1597","article-title":"Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study","volume":"98","author":"Bertrand","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ancard.2017.10.012_bib0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"issue":"10081","key":"10.1016\/j.ancard.2017.10.012_bib0440","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(17)30751-1","article-title":"Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial","volume":"389","author":"Ohman","year":"2017","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ancard.2017.10.012_bib0355","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"New Eng J"},{"key":"10.1016\/j.ancard.2017.10.012_bib0360","unstructured":"Valgimigli M, et al. GLOBAL LEADERS: a clinical study comparing two forms of anti-platelet therapy after stent implantation ClinicalTrials.gov: NCT01813435."},{"key":"10.1016\/j.ancard.2017.10.012_bib0365","unstructured":"Mehran R, et al. Ticagrelor with aspirin or alone in high-risk patients after coronary intervention (TWILIGHT) ClinicalTrials.gov: NCT02270242."},{"issue":"16","key":"10.1016\/j.ancard.2017.10.012_bib0370","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2011.1529","article-title":"Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis","volume":"306","author":"Cayla","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ancard.2017.10.012_bib0375","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jacc.2009.12.071","article-title":"Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2\u00a0loss-of-funtion allele or proton pump inhibitor co-administration: a systematic meta-analysis","volume":"56","author":"Hulot","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ancard.2017.10.012_bib0380","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(09)60682-6","article-title":"Cytochrome P450 2C19\u00a0polymorphism and clopidogrel after MI","volume":"373","author":"Collet","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ancard.2017.10.012_bib0445","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc06-1625","article-title":"Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation","volume":"30","author":"Geisler","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ancard.2017.10.012_bib0390","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCULATIONAHA.106.667741","article-title":"Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study","volume":"115","author":"Angiolillo","year":"2007","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ancard.2017.10.012_bib0395","first-page":"1676","article-title":"Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study","volume":"38","author":"Hauguel-Moreau","year":"2016","journal-title":"Eur Heart J"},{"issue":"9906","key":"10.1016\/j.ancard.2017.10.012_bib0400","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","article-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2\u00a0year results from a prospective observational study","volume":"382","author":"Mehran","year":"2013","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ancard.2017.10.012_bib0405","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30\u00a0months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.ancard.2017.10.012_bib0410","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ancard.2017.10.012_bib0415","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jama.2015.1671","article-title":"Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: the dual antiplatelet therapy randomized clinical trial","volume":"313","author":"Kereiakes","year":"2015","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ancard.2017.10.012_bib0420","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"issue":"10055","key":"10.1016\/j.ancard.2017.10.012_bib0425","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(16)31323-X","article-title":"Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial","volume":"388","author":"Cayla","year":"2016","journal-title":"Lancet"},{"issue":"10104","key":"10.1016\/j.ancard.2017.10.012_bib0430","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","article-title":"Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial","volume":"390","author":"Sibbing","year":"2017","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.ancard.2017.10.012_bib0435","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1\u00a0year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ancard.2017.10.012_bib0220","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"}],"container-title":["Annales de Cardiologie et d'Ang\u00e9iologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392817301439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003392817301439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T06:40:37Z","timestamp":1535265637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003392817301439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0003392817301439"],"URL":"https:\/\/doi.org\/10.1016\/j.ancard.2017.10.012","relation":{},"ISSN":["0003-3928"],"issn-type":[{"value":"0003-3928","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombose coronaire\u00a0: physiopathologie et traitement \u00e0 l\u2019\u00e8re de la m\u00e9decine personnalis\u00e9e","name":"articletitle","label":"Article Title"},{"value":"Annales de Cardiologie et d'Ang\u00e9iologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ancard.2017.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}